YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Merck buying Cubist Pharmaceuticals for $8.4B

Posted online
Merck is buying Cubist Pharmaceuticals for $8.4 billion, illustrating a new emphasis on combating so-called "superbugs" that are drawing dire warnings from global health organizations.

The Associated Press reports the transaction includes $1.1 billion in debt.

The World Health organization warned in April that without a coordinated effort, "the world is headed for a post-antibiotic era, in which common infections and minor injuries which have been treatable for decades can once again kill."

Read more from The Associated Press.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences